General Information of the Cell Line
Cell Line ID
CL000309
Cell Line Name
NCTC clone 929
Synonyms
NCTC 929
NCTC-929
NCTC929
NCTC-929L
L cell
L cells
L-cell
L-cells
L cell line
L
Strain L-929
L-929
L 929
L929
L929(NCTC)
Clone 929
Earles's cells
Earle's L cells
Category
Spontaneously immortalized cell line
Organism
Mus musculus (Mouse)
Cellosaurus ID
CVCL_0462
Tissue Information
Connective tissue
Disease None
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Compound ID Compound Name Compound Formula
CP0134845
1-(17-fluoro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21FN2O
 1
1
IC50 = 1.148 nM
   TI
   LI
   LO
   TS
CP0400980
1-(17-chloro-3,13-dioxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C18H19ClN2O2
 1
1
IC50 = 1.905 nM
   TI
   LI
   LO
   TS
CP0123725
N,N-dimethyl-1-(17-methyl-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)methanamine
   Show/Hide
C20H24N2O
 1
1
IC50 = 3.09 nM
   TI
   LI
   LO
   TS
CP0105756
1-(17-chloro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21ClN2O
 1
1
IC50 = 3.467 nM
   TI
   LI
   LO
   TS
CP0438133
N,N-dimethyl-3-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)propan-1-amine
   Show/Hide
C21H26N2O
 1
1
IC50 = 3.89 nM
   TI
   LI
   LO
   TS
CP0393174
1-(16-fluoro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21FN2O
 1
1
IC50 = 6.918 nM
   TI
   LI
   LO
   TS
CP0026495
CHEBI:51137
   Show/Hide
C18H20N2
 1
1
IC50 = 10.47 nM
   TI
   LI
   LO
   TS
CP0497647
N,N-dimethyl-1-(10-methyl-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl)methanamine
   Show/Hide
C20H24N2O
 1
1
IC50 = 10.47 nM
   TI
   LI
   LO
   TS
CP0091879
1-(9,17-difluoro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7(12),8,10,15,17-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H20F2N2O
 1
1
IC50 = 10.72 nM
   TI
   LI
   LO
   TS
CP0183894
N-methyl-1-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine
   Show/Hide
C18H20N2O
 1
1
IC50 = 13.18 nM
   TI
   LI
   LO
   TS
CP0467988
3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-ylmethanamine
   Show/Hide
C17H18N2O
 1
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
CP0431008
N,N-dimethyl-1-(17-phenyl-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)methanamine
   Show/Hide
C25H26N2O
 1
1
IC50 = 22.39 nM
   TI
   LI
   LO
   TS
CP0734983
Dimethyl-(2,3,3a,8-tetrahydro-1-oxa-12b-aza-dibenzo[e,h]azulen-2-ylmethyl)-amine
   Show/Hide
C19H22N2O
 1
1
IC50 = 22.91 nM
   TI
   LI
   LO
   TS
CP0453941
1-(15-fluoro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21FN2O
 1
1
IC50 = 23.99 nM
   TI
   LI
   LO
   TS
CP0384022
4-(pyrrolidin-1-ylmethyl)-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaene
   Show/Hide
C21H24N2O
 1
1
IC50 = 25.12 nM
   TI
   LI
   LO
   TS
CP0405608
1-(11-fluoro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21FN2O
 1
1
IC50 = 31.62 nM
   TI
   LI
   LO
   TS
CP0497667
1-(18-chloro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21ClN2O
 1
1
IC50 = 32.36 nM
   TI
   LI
   LO
   TS
CP0402198
N-ethyl-N-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-ylmethyl)ethanamine
   Show/Hide
C21H26N2O
 1
1
IC50 = 42.66 nM
   TI
   LI
   LO
   TS
CP0435998
N,N-dimethyl-1-(8-methyl-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine
   Show/Hide
C20H24N2O
 1
1
IC50 = 47.86 nM
   TI
   LI
   LO
   TS
CP0464753
1-(9-fluoro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21FN2O
 1
1
IC50 = 53.7 nM
   TI
   LI
   LO
   TS
CP0392920
N,N-dimethyl-1-[8-(trifluoromethyl)-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H21F3N2O
 1
1
IC50 = 67.61 nM
   TI
   LI
   LO
   TS
CP0094561
N,N-dimethyl-2-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)ethanamine
   Show/Hide
C20H24N2O
 1
1
IC50 = 91.2 nM
   TI
   LI
   LO
   TS
CP0464885
N,N-dimethyl-1-(15-methyl-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine
   Show/Hide
C20H24N2O
 1
1
IC50 = 91.2 nM
   TI
   LI
   LO
   TS
CP0475727
4-(morpholin-4-ylmethyl)-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaene
   Show/Hide
C21H24N2O2
 1
1
IC50 = 141.25 nM
   TI
   LI
   LO
   TS
CP0421446
4-[(4-methylpiperazin-1-yl)methyl]-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaene
   Show/Hide
C22H27N3O
 1
1
IC50 = 281.84 nM
   TI
   LI
   LO
   TS
CP0372936
1-(9-methoxy-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C20H24N2O2
 1
1
IC50 = 302 nM
   TI
   LI
   LO
   TS
CP0404509
N,N-dimethyl-1-[11-(trifluoromethyl)-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H21F3N2O
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0392599
N-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-ylmethyl)-N-propan-2-ylpropan-2-amine
   Show/Hide
C23H30N2O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0422415
4-[[4-(3-chlorophenyl)piperazin-1-yl]methyl]-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaene
   Show/Hide
C27H28ClN3O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0437491
2,2,2-trifluoro-N-methyl-N-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-ylmethyl)acetamide
   Show/Hide
C20H19F3N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0460072
N,N-dimethyl-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaene-4-carboxamide
   Show/Hide
C19H20N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0461043
4-[(4-phenylpiperazin-1-yl)methyl]-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaene
   Show/Hide
C27H29N3O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0461320
2-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-ylmethyl)isoindole-1,3-dione
   Show/Hide
C25H20N2O3
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0463614
N,N-dimethyl-4-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)butan-1-amine
   Show/Hide
C22H28N2O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0464735
4-(piperazin-1-ylmethyl)-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaene
   Show/Hide
C21H25N3O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0476618
4-(1,3-dihydroisoindol-2-ylmethyl)-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaene
   Show/Hide
C25H24N2O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0383066
1-(11-chloro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21ClN2O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0508933
1-(8-fluoro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl)-N,N-dimethylmethanamine
   Show/Hide
C19H21FN2O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0515871
N,N-dimethyl-1-[9-(trifluoromethyl)-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H21F3N2O
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0050128
N,N-dimethyl-1-[(2S,4R,6R)-3-oxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H23NO
 1
1
Ki = 2.5 nM
   TI
   LI
   LO
   TS
CP0530334
N,N-dimethyl-1-[(4S,6R)-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C19H22N2O
 1
1
Ki = 2.5 nM
   TI
   LI
   LO
   TS
CP0319460
((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
   Show/Hide
C19H20BrNO2
 1
1
Ki = 3 nM
   TI
   LI
   LO
   TS
CP0311945
((2S,3aS,12bS)-11-Chloro-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
   Show/Hide
C19H20ClNO2
 1
1
Ki = 5 nM
   TI
   LI
   LO
   TS
CP0251195
((2R,3aS,12bS)-11-Chloro-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
   Show/Hide
C19H20ClNO2
 1
1
Ki = 11 nM
   TI
   LI
   LO
   TS
CP0716967
Dimethyl-[(2R,3aR,12bS)-1-(2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-yl)methyl]-amine
   Show/Hide
C19H21NO2
 1
1
Ki = 16 nM
   TI
   LI
   LO
   TS
CP0461357
1-Methyl-4-[(3aR,12bS)-1-(2,3,3a,12b-tetrahydro-1-oxa-8-thia-dibenzo[e,h]azulen-2-yl)methyl]-piperazine
   Show/Hide
C22H26N2OS
 1
1
Ki = 17.3 nM
   TI
   LI
   LO
   TS
CP0422236
N,N-dimethyl-1-[(2S,4S,6R)-3-oxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H23NO
 1
1
Ki = 19.6 nM
   TI
   LI
   LO
   TS
CP0478245
N,N-dimethyl-1-[(2S,6R)-3-oxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H23NO
 1
1
Ki = 21.7 nM
   TI
   LI
   LO
   TS
CP0366089
((2S,3aS,12bS)-11-Methoxy-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
   Show/Hide
C20H23NO3
 1
1
Ki = 22 nM
   TI
   LI
   LO
   TS
CP0454651
N,N-dimethyl-1-[(2S,6R)-3-oxa-13-thiatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C19H21NOS
 1
1
Ki = 30.7 nM
   TI
   LI
   LO
   TS
CP0275194
8-((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-3-methyl-7-oxa-8-aza-bicyclo[4.2.0]octa-1(6),2,4-triene
   Show/Hide
C24H20BrNO3
 1
1
Ki = 36 nM
   TI
   LI
   LO
   TS
CP0454625
1-[(2S,6R)-3,13-dioxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]-N,N-dimethylmethanamine
   Show/Hide
C19H21NO2
 1
1
Ki = 37 nM
   TI
   LI
   LO
   TS
CP0448928
N-methyl-1-[(2S,6R)-3-oxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C19H21NO
 1
1
Ki = 48.6 nM
   TI
   LI
   LO
   TS
CP0470578
1-(3-Chloro-phenyl)-4-[(3aR,12bS)-1-(3,3a,8,12b-tetrahydro-2H-1-oxa-dibenzo[e,h]azulen-2-yl)methyl]-piperazine
   Show/Hide
C28H29ClN2O
 1
1
Ki = 56 nM
   TI
   LI
   LO
   TS
CP0077877
((2R,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
   Show/Hide
C19H20BrNO2
 1
1
Ki = 65 nM
   TI
   LI
   LO
   TS
CP0438782
4-Phenyl-1-[(3aR,12bS)-1-(2,3,3a,12b-tetrahydro-1-oxa-8-thia-dibenzo[e,h]azulen-2-yl)methyl]-piperidine
   Show/Hide
C28H29NOS
 1
1
Ki = 68.7 nM
   TI
   LI
   LO
   TS
CP0453367
N-methyl-1-[(2R,4S,6S)-3-oxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C19H21NO
 1
1
Ki = 74.1 nM
   TI
   LI
   LO
   TS
CP0438192
N,N-dimethyl-1-[(2S,6R)-13-methyl-3-oxa-13-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H24N2O
 1
1
Ki = 80.7 nM
   TI
   LI
   LO
   TS
CP0457342
2-{4-[(3aR,12bS)-1-(3,3a,8,12b-Tetrahydro-2H-1-oxa-dibenzo[e,h]azulen-2-yl)methyl]-piperazin-1-yl}-ethanol
   Show/Hide
C24H30N2O2
 1
1
Ki = 86.5 nM
   TI
   LI
   LO
   TS
CP0438554
1-[(2S,6R)-3,13-dioxatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),7,9,11,15,17-hexaen-4-yl]-N,N-dimethylmethanamine
   Show/Hide
C20H23NO2
 1
1
Ki = 90.5 nM
   TI
   LI
   LO
   TS
CP0035139
1-[(2R,4R,6S)-3,13-dioxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]-N,N-dimethylmethanamine
   Show/Hide
C19H21NO2
 1
1
Ki = 92 nM
   TI
   LI
   LO
   TS
CP0463465
1-[(2S,6S)-3,13-dioxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]-N,N-dimethylmethanamine
   Show/Hide
C19H21NO2
 1
1
Ki = 92.6 nM
   TI
   LI
   LO
   TS
CP0312008
8-[[(2S,4S,6S)-17-bromo-3,13-dioxatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl]methyl]-N,N-dimethyl-7-oxa-8-azabicyclo[4.2.0]octa-1(6),2,4-trien-3-amine
   Show/Hide
C25H23BrN2O3
 1
1
Ki = 95 nM
   TI
   LI
   LO
   TS
CP0077886
8-((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-7-oxa-8-aza-bicyclo[4.2.0]octa-1(6),2,4-triene-3-carboxylic acid ethyl ester
   Show/Hide
C26H22BrNO5
 1
1
Ki = 97 nM
   TI
   LI
   LO
   TS
CP0448518
N,N-dimethyl-1-[(2S,6S)-3-oxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H23NO
 1
1
Ki = 102 nM
   TI
   LI
   LO
   TS
CP0250615
((2S,3aS,12bS)-11-Fluoro-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
   Show/Hide
C19H20FNO2
 1
1
Ki = 104 nM
   TI
   LI
   LO
   TS
CP0420430
N,N-dimethyl-1-[(2R,4S,6S)-3-oxatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl]methanamine
   Show/Hide
C20H23NO
 1
1
Ki = 104 nM
   TI
   LI
   LO
   TS
CP0237838
8-((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-7-oxa-8-aza-bicyclo[4.2.0]octa-1(6),2,4-triene-3-carbonitrile
   Show/Hide
C24H17BrN2O3
 1
1
Ki = 185 nM
   TI
   LI
   LO
   TS
CP0254576
8-((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-3-morpholin-4-ylmethyl-7-oxa-8-aza-bicyclo[4.2.0]octa-1(6),2,4-triene
   Show/Hide
C28H27BrN2O4
 1
1
Ki = 189 nM
   TI
   LI
   LO
   TS
CP0319461
((2R,3aS,12bS)-11-Methoxy-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
   Show/Hide
C20H23NO3
 1
1
Ki = 193 nM
   TI
   LI
   LO
   TS
CP0092119
8-((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-7-oxa-8-aza-bicyclo[4.2.0]octa-1(6),2,4-trien-3-ylamine
   Show/Hide
C23H19BrN2O3
 1
1
Ki = 255 nM
   TI
   LI
   LO
   TS
CP0077915
1-[8-((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-7-oxa-8-aza-bicyclo[4.2.0]octa-1(6),2,4-trien-3-yl]-azetidin-2-one
   Show/Hide
C26H21BrN2O4
 1
1
Ki = 306 nM
   TI
   LI
   LO
   TS
CP0408686
8-((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-3-morpholin-4-yl-7-oxa-8-aza-bicyclo[4.2.0]octa-1(6),2,4-triene
   Show/Hide
C27H25BrN2O4
 1
1
Ki = 306 nM
   TI
   LI
   LO
   TS
CP0160384
8-((2S,3aS,12bS)-11-Bromo-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-3-phenyl-7-oxa-8-aza-bicyclo[4.2.0]octa-1(6),2,4-triene
   Show/Hide
C29H22BrNO3
 1
1
Ki = 307 nM
   TI
   LI
   LO
   TS
CP0146501
((2R,3aS,12bS)-11-Fluoro-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
   Show/Hide
C19H20FNO2
 1
1
Ki = 423 nM
   TI
   LI
   LO
   TS
CP0383041
4-[(3aR,12bS)-1-(3,3a,8,12b-Tetrahydro-2H-1-oxa-dibenzo[e,h]azulen-2-yl)methyl]-morpholine
   Show/Hide
C22H25NO2
 1
1
Ki = 433 nM
   TI
   LI
   LO
   TS
CP0401076
1-Methyl-4-[(3aR,12bS)-1-(3,3a,8,12b-tetrahydro-2H-1-oxa-dibenzo[e,h]azulen-2-yl)methyl]-piperazine
   Show/Hide
C23H28N2O
 1
1
Ki = 433 nM
   TI
   LI
   LO
   TS
CP0403652
(4-Fluoro-phenyl)-{1-[(3aR,12bS)-1-(3,3a,8,12b-tetrahydro-2H-1-oxa-dibenzo[e,h]azulen-2-yl)methyl]-piperidin-4-yl}-methanone
   Show/Hide
C30H30FNO2
 1
1
Ki = 433 nM
   TI
   LI
   LO
   TS
CP0461004
1-[(2S,6R)-3,14-dioxatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),7,9,11,15,17-hexaen-4-yl]-N,N-dimethylmethanamine
   Show/Hide
C20H23NO2
 1
1
Ki = 1064 nM
   TI
   LI
   LO
   TS
CP0480878
4-Phenyl-1-[(3aR,12bS)-1-(3,3a,8,12b-tetrahydro-2H-1-oxa-dibenzo[e,h]azulen-2-yl)methyl]-piperidine
   Show/Hide
C29H31NO
 1
1
Ki = 1088 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0023959
(-)-Epigallocatechin gallate
   Show/Hide
C22H18O11  1
1
IC50 = 82300 nM
   TI
   LI
   LO
   TS
CP0036222
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12  1
1
IC50 = 30000 nM
   TI
   LI
   LO
   TS
CP0036382
CAS_52-53-9
   Show/Hide
C27H38N2O4  3
1
IC50 = 88000 nM
   TI
   LI
   LO
   TS
2
IC50 = 89000 nM
   TI
   LI
   LO
   TS
3
IC50 = 89200 nM
   TI
   LI
   LO
   TS
CP0049207
(S)-2-{4-[3-(2,4-Diamino-6-oxo-1,6-dihydro-pyrimidin-5-yl)-propylamino]-benzoylamino}-pentanedioic acid
   Show/Hide
C19H24N6O6  1
1
IC50 = 88 nM
   TI
   LI
   LO
   TS
CP0078757
(E)-3-((3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)(3-(dimethylamino)-3-oxopropylthio)methylthio)propanoic acid
   Show/Hide
C26H27ClN2O3S2  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0376149
(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-ol
   Show/Hide
C20H24O7  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0376150
[(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] (E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
   Show/Hide
C32H36O11  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0376714
[(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3-[(3,4-dimethoxybenzoyl)amino]-4-fluorobenzoate
   Show/Hide
C36H36FNO11  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0381563
1,16-Bis[40-((6-methyl)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13,16-hexaoxahexadecane
   Show/Hide
C42H42O10  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0385379
[(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] (E)-3-(3,4-dimethoxyphenyl)prop-2-enoate
   Show/Hide
C31H34O10  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0392213
7-[2-[[1-[2-[2-[4-(4-oxochromen-2-yl)phenoxy]ethoxy]ethyl]triazol-4-yl]methoxy]ethoxy]-2-phenylchromen-4-one
   Show/Hide
C39H33N3O8  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0392214
7-[3-[1-[2-[2-(4-oxo-2-phenylchromen-7-yl)oxyethoxy]ethyl]triazol-4-yl]propoxy]-2-phenylchromen-4-one
   Show/Hide
C39H33N3O7  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0392220
6-methyl-2-[4-[4-[1-[2-[2-[4-(4-oxochromen-2-yl)phenoxy]ethoxy]ethyl]triazol-4-yl]butoxy]phenyl]chromen-4-one
   Show/Hide
C41H37N3O7  1
1
IC50 > 57000 nM
   TI
   LI
   LO
   TS
CP0394430
7-[2-[benzyl-[[1-[2-[2-[4-(6-fluoro-4-oxochromen-2-yl)phenoxy]ethoxy]ethyl]triazol-4-yl]methyl]amino]ethoxy]-2-phenylchromen-4-one
   Show/Hide
C46H39FN4O7  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0400853
[(2R,3S)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3-[(3,4-dimethoxybenzoyl)amino]-4-fluorobenzoate
   Show/Hide
C36H36FNO11  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0411926
[(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 4-methoxybenzoate
   Show/Hide
C28H30O9  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0413620
N-[5-[[4-(diethylamino)phenyl]methyl]-4-[(3,4-dimethoxyphenyl)methyl]-1-methylimidazol-2-yl]-3,4,5-trimethoxybenzamide
   Show/Hide
C34H42N4O6  1
1
IC50 = 47400 nM
   TI
   LI
   LO
   TS
CP0426779
2-[4-[4-[1-[2-[2-[4-(6-fluoro-4-oxochromen-2-yl)phenoxy]ethoxy]ethyl]triazol-4-yl]butoxy]phenyl]-6-methylchromen-4-one
   Show/Hide
C41H36FN3O7  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0433607
[(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]-4-fluorobenzoate
   Show/Hide
C38H38FNO11  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0433749
[(2R,3S)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 4-fluoro-3-[(3,4,5-trimethoxybenzoyl)amino]benzoate
   Show/Hide
C37H38FNO12  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0437292
7-[2-[benzyl-[[1-[2-[2-[2-[4-(6-fluoro-4-oxochromen-2-yl)phenoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methyl]amino]ethoxy]-2-phenylchromen-4-one
   Show/Hide
C48H43FN4O8  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0444644
[(2R,3S)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] (E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
   Show/Hide
C32H36O11  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0449125
[(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4-dimethoxybenzoate
   Show/Hide
C29H32O10  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0455369
7-[4-[1-[2-[2-[4-(4-oxochromen-2-yl)phenoxy]ethoxy]ethyl]triazol-4-yl]butoxy]-2-phenylchromen-4-one
   Show/Hide
C40H35N3O7  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0457483
[(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3-(dimethylamino)-4-fluorobenzoate
   Show/Hide
C29H32FNO8  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0499273
[(2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 4-fluoro-3-[[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]amino]benzoate
   Show/Hide
C39H40FNO12  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0562097
N-phenyl-N'-trityloxyoctanediamide
   Show/Hide
C33H34N2O3  1
1
CC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0847075
(2R,3S)-5,7-Dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 3-((E)-3-(3,4-dimethoxyphenyl)acrylamido)-4-fluorobenzoate
   Show/Hide
C38H38FNO11  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0849538
(2R,3R)-5,7-Dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 3-acetamido-4-fluorobenzoate
   Show/Hide
C29H30FNO9  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Connective tissue)
Cell Line Name Organism Disease
human L929 Homo sapiens (Human) -
LTK- Mus musculus (Mouse) -
L-M(TK-) Mus musculus (Mouse) -
A-9 Mus musculus (Mouse) -
L Wnt-3A Mus musculus (Mouse) -
LAP1 Mus musculus (Mouse) -
LV2 Mus musculus (Mouse) -